The University of Chicago Header Logo

Connection

Michael Becker to Placebos

Back to Details
This is a "connection" page, showing publications Michael Becker has written about Placebos.
Michael Becker
Connection Strength
0.061
Placebos
  1. Febuxostat (TMX-67), a novel, non-purine, selective inhibitor of xanthine oxidase, is safe and decreases serum urate in healthy volunteers. Nucleosides Nucleotides Nucleic Acids. 2004 Oct; 23(8-9):1111-6.
    View in: PubMed
    Score: 0.061
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.